ZA85910B - A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form - Google Patents

A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form

Info

Publication number
ZA85910B
ZA85910B ZA85910A ZA85910A ZA85910B ZA 85910 B ZA85910 B ZA 85910B ZA 85910 A ZA85910 A ZA 85910A ZA 85910 A ZA85910 A ZA 85910A ZA 85910 B ZA85910 B ZA 85910B
Authority
ZA
South Africa
Prior art keywords
crystalline
novel
stable
preparation
prazosin hydrochloride
Prior art date
Application number
ZA85910A
Other languages
English (en)
Inventor
Stig Olof Engelbert
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA85910B publication Critical patent/ZA85910B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA85910A 1984-06-25 1985-02-06 A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form ZA85910B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (1)

Publication Number Publication Date
ZA85910B true ZA85910B (en) 1985-09-25

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85910A ZA85910B (en) 1984-06-25 1985-02-06 A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form

Country Status (17)

Country Link
US (2) US4739055A (online.php)
JP (1) JPS6115881A (online.php)
AT (1) AT389117B (online.php)
AU (1) AU566814B2 (online.php)
BE (1) BE900925A (online.php)
CH (1) CH661045A5 (online.php)
DE (1) DE3429415A1 (online.php)
FI (1) FI79107C (online.php)
FR (1) FR2567124B1 (online.php)
GB (1) GB2160861B (online.php)
IL (1) IL73267A (online.php)
IT (1) IT1224142B (online.php)
LU (1) LU85616A1 (online.php)
NL (1) NL8403250A (online.php)
NZ (1) NZ209962A (online.php)
PT (1) PT79411B (online.php)
ZA (1) ZA85910B (online.php)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
EE05643B1 (et) * 2001-02-24 2013-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
AU2008290582B2 (en) * 2007-08-17 2014-08-14 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX370599B (es) * 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru) 2008-12-23 2015-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Солевые формы органического соединения
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en) 2011-07-15 2020-06-23 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156532C (online.php) *
US2969375A (en) * 1961-01-24 Certification of correction
NL54420C (online.php) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
JPH0481993B2 (online.php) 1992-12-25
GB2160861B (en) 1987-11-18
BE900925A (fr) 1985-02-15
DE3429415C2 (online.php) 1990-05-03
GB2160861A (en) 1986-01-02
FI842544A0 (fi) 1984-06-25
FR2567124B1 (fr) 1990-09-21
CH661045A5 (de) 1987-06-30
PT79411B (en) 1986-09-15
IL73267A (en) 1988-06-30
FI79107C (fi) 1989-11-10
US4873330A (en) 1989-10-10
ATA344184A (de) 1989-03-15
AU566814B2 (en) 1987-10-29
NL8403250A (nl) 1986-01-16
FI79107B (fi) 1989-07-31
PT79411A (en) 1984-11-01
NZ209962A (en) 1987-06-30
JPS6115881A (ja) 1986-01-23
FR2567124A1 (fr) 1986-01-10
IT1224142B (it) 1990-09-26
GB8424999D0 (en) 1984-11-07
LU85616A1 (fr) 1985-06-04
AU3451084A (en) 1986-01-02
US4739055A (en) 1988-04-19
FI842544L (fi) 1985-12-26
IT8423292A0 (it) 1984-10-24
AT389117B (de) 1989-10-25
DE3429415A1 (de) 1986-01-02
IL73267A0 (en) 1985-01-31

Similar Documents

Publication Publication Date Title
IL73267A0 (en) Novel anhydrous,stable,crystalline delta-form of prazosin hydrochloride and a novel process for the preparation of said crystalline delta-form
HUT38361A (en) Process for preparing new crystalline modifications
HUT44257A (en) Process for preparing crystalline cefalosporinhydrate
YU191188A (en) Process for preparing new ammonia compounds
PT79963A (en) Process for the preparation of asymetric diesthers
PT81463A (en) Process for preparing novel 5-amino-4-hidroxyvalerylderivatives
SG69290G (en) Pleuromutilin derivatives,process for their preparation and their use
ZA862929B (en) Process for preparing(z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl-cyclopropane hydrochloride
YU156985A (en) Process for producing ammonia
DE3571028D1 (en) A process for the preparation of p-isononanoyloxybenzenenesulphonate
YU228688A (en) Process for preparing new ammonia compounds
GB2167066B (en) Process for producing urea
PT81522B (en) Process for preparing basic v1-vasopressin antagonists
PH23601A (en) Process for preparing urea
DE3665875D1 (en) Crystalline polyester-imides, process for production thereof, and use thereof
CS690485A2 (en) Process for preparing aminoalcohols
PT81510A (en) Process for preparing v1-vasopressin antagonists
PT85372A (en) Bisucaderin a process for producing this compound and its use as a medicament
ZA851190B (en) Pleuromutilin derivatives,process for their preparation and their use
YU45030B (en) Process for preparing crystalline cimetidine
HUT44564A (en) Novel process for preparing piroxicam-propharmakon
DE3564274D1 (en) Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist
HUT46594A (en) Process for producing ammonia
CS987985A1 (en) Crystalline form of a 1-benzydril-4-aryl--piperazindyhydrochloride and process for preparing thereof
YU5488A (en) Process for producing herbicidal pyridinsulphonyl ureas